ESC 365 - Risk assessing dyslipidemia for cardiovascular risk: why haven’t we solved the problem?

Open Access

Risk assessing dyslipidemia for cardiovascular risk: why haven’t we solved the problem?

Session: Assessing atherosclerosis: risks, goals and strategies to minimize cardiovascular risk post-myocardial infarction

Topic: Lipids

Speaker: Doctor E. Bohula (Boston, US)

Sponsored by MSD

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Erin Bohula

Brigham and Women's Hospital, Boston (United States of America)

13 presentations

0 follower

5 more presentations in this session

Introduction.

Targeting treatment for dyslipidemia: goals, guidelines and grades of recommendations.

Speaker: Professor L. Tokgozoglu (Ankara, TR)

Tailoring therapy for dyslipidemia: from risk assessment to effective treatment.

Speaker: Doctor A. Gitt (Ludwigshafen, DE)

Complex cases in atherosclerosis: what to do post-MI?

Speaker: Professor H. Drexel (Feldkirch, AT)

Panel discussion and Q&A.

Access the full session

Assessing atherosclerosis: risks, goals and strategies to minimize cardiovascular risk post-myocardial infarction

Speakers: Doctor E. Bohula, Professor L. Tokgozoglu, Doctor A. Gitt, Professor H. Drexel

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources